NASDAQ: CHMA - Chiasma, Inc.

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Chiasma, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Chiasma, Inc.

Chiasma, Inc., клиническая биофармацевтическая компания на поздних стадиях, специализируется на разработке пероральных препаратов с использованием технологической платформы временных усилителей проницаемости для лечения редких и серьезных хронических заболеваний во всем мире. Компания разрабатывает капсулы октреотида для перорального применения для взрослых пациентов под названием MYCAPSSA, которые находятся в фазе III клинических испытаний для лечения акромегалии, состояния, которое приводит к выработке организмом избыточного гормона роста. Chiasma, Inc.

more details
была основана в 2001 году со штаб-квартирой в Нидхэме, Массачусетс.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2015-07-16
ISIN US16706W1027
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.chiasma.com
Цена ао 3.76
Change price per day: 0% (3.76)
Change price per week: 0% (3.76)
Change price per month: 0% (3.76)
Change price per 3 month: 0% (3.76)
Change price per half year: 0% (3.76)
Change price per year: 0% (3.76)
Change price per 3 year: 0% (3.76)
Change price per 5 year: -42.77% (6.57)
Change price per 10 year: 0% (3.76)
Change price per year to date: 0% (3.76)
All parameters

Underestimation

Title Value Grade
P/S 71.22 1
P/BV 3.79 4
P/E 0 0
EV/EBITDA -2.23 0
Total: 3.38

Efficiency

Title Value Grade
ROA, % -73.05 0
ROE, % -133.81 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0132 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % -95.89 0
Yield Ebitda, % 166.17 10
Yield EPS, % 30 5
Total: 7
More

Institutions Volume Share, %
Mpm Asset Management, LLC 5736296 9.91
Stonepine Capital Management Llc 4940273 8.53
Eventide Asset Management, LLC 3000326 5.18
Rock Springs Capital Management LP 2174583 3.76
Fidelity SelectCo, LLC 1625699 2.57
BlackRock Fund Advisors 1405587 2.22
Fidelity Management & Research Company LLC 1277791 2.02
Woodline Partners LP 1216512 2.1
ARCH VENTURE CORP 1196776 2.07
Bruce & Co Inc 1150000 1.99
New Leaf Venture Partners, L.L.C. 1135700 1.96
Sofinnova Ventures 1047354 1.81
Northern Trust Investments Inc 860243 1.36
Manulife Investment Management 744623 1.29
Ikarian Capital, LLC 730299 1.26
Hauck & Aufhäuser Fund Services S.A. 661996 1.15
Hauck & Aufhäuser Fund Services S.A. 661996 1.05
Bruce & Co Inc 450000 0.78
John Hancock Investment Management LLC 363605 0.57
Teachers Advisors LLC 352788 0.56
Apo Asset Management GmbH 284958 0.49
Prudential Retirement Services 159763 0.28
Dafna Capital Management LLC 153208 0.27
Reichmuth & Co Integrale Vermogensverwaltung AG 99544 0.17
SEI Investments Management Corp 86276 0.14
Bogle 74500 0.12
Mandarine Gestion 51000 0.08
INKA Internationale KAG mbH 41572 0.07
Manulife Investment Management (US) LLC 20172 0.03
PGIM Investments LLC 12242 0.02
Invesco Advisers, Inc. 7900 0.01
Great Lakes Advisors, LLC 2277 0
Defiance ETFs, LLC 1320 0



Head Job title Payment Year of birth
Mr. Raj Kannan Pres, CEO & Director 827.55k 1964 (61 year)
Mr. Anand Varadan Exec. VP & Chief Commercial Officer 542.27k 1967 (58 years)
Mr. John Brendan Doyle Sr. VP, CFO & Treasurer N/A 1977 (48 years)
Mr. Drew Enamait VP of Fin. & Admin. N/A 1974 (51 year)
Ms. Dawn Schottlandt CFA VP of Investor Relations & Corp. Communications N/A
Mr. Lee G. Giguere VP of Gen. Counsel & Sec. N/A 1980 (45 years)
Mr. Derek Brown VP of Marketing N/A
Mr. Joe Lyons Exec. Director of HR N/A
Dr. William H. Ludlam Sr. VP of Clinical Devel. & Medical Affairs N/A 1966 (59 years)
Mr. David M. Schubert Sr. VP of Regulatory & Quality N/A

Address: United States, Needham, MA , Building C East - open in Google maps, open in Yandex maps
Website: http://www.chiasma.com